| Literature DB >> 22545120 |
Angela Cánovas1, Ramona N Pena, David Gallardo, Oscar Ramírez, Marcel Amills, Raquel Quintanilla.
Abstract
BACKGROUND: The main goal of the present study was to analyse the genetic architecture of mRNA expression in muscle, a tissue with an outmost economic importance for pig breeders. Previous studies have used F(2) crosses to detect porcine expression QTL (eQTL), so they contributed with data that mostly represents the between-breed component of eQTL variation. Herewith, we have analysed eQTL segregation in an outbred Duroc population using two groups of animals with divergent fatness profiles. This approach is particularly suitable to analyse the within-breed component of eQTL variation, with a special emphasis on loci involved in lipid metabolism. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 22545120 PMCID: PMC3335821 DOI: 10.1371/journal.pone.0035583
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Distribution of high and low quality porcine Affymetrix probes (and corresponding number of genes) regulated by either cis- or trans-acting eQTL.
| N. eQTL, N. affected probes, N. genes | |
| Total | 613 eQTL, 569 probes, 536 genes |
| eQTL with mapped target-probes | 478 eQTL, 451 probes, 427 genes |
Figure 1Distribution of genome-wide expression QTL amongst pig chromosomes.
(A) Total number of eQTL and (B) cis-acting (▪) and trans-acting (▴) eQTL.
Figure 2Effect of the genome-wide P-value cutoff on the relative frequencies of trans- and cis-eQTL.
Figure 3Porcine genomic regions with eQTL regulating more than four genes (eQTL hotspots).
List of genes regulated by each one of the 11 trans-regulatory hotspots regions.
| Chromosome | Position | N regulated genes | List of regulated genes |
|
| 10 cM | 11 |
|
|
| 122 cM | 7 |
|
|
| 24 cM | 16 |
|
| 30 cM | 14 |
| |
|
| 114 cM | 16 |
|
| 124 cM | 13 |
| |
|
| 66 cM | 10 |
|
| 124 cM | 9 |
| |
|
| 134 cM | 14 |
|
|
| 88 cM | 13 |
|
|
| 40 cM | 4 |
|
Figure 4Global GO enrichment analysis performed with DAVID software on the list of eQTL-regulated genes.
(A) List of most significant GO terms represented in the biological process category (P<0.01). (B) List of most significant GO terms represented in the molecular function category (P<0.01).
Genome-wide significant cis-eQTL for gluteus medius expression traits whose target genes are functionally related to lipid metabolism and fat deposition.
| eQTL location and significance | QTL positional concordance in the same population | ||||
|
| Chromosome | Position | F-value | Nominal | Linked Trait |
|
| SSC01 | 28 cM | 4.81 | 0.000533 | - |
|
| SSC01 | 40 cM | 5.10 | 0.000316 | - |
|
| SSC01 | 64 cM | 5.03 | 0.000359 | IMF |
|
| SSC02 | 122 cM | 6.16 | 0.000048 | - |
|
| SSC03 | 10 cM | 5.62 | 0.000125 | IMF; Vaccenic FA |
|
| SSC03 | 10 cM | 5.60 | 0.000129 | IMF; Vaccenic FA |
|
| SSC03 | 24 cM | 7.78 | 0.000003 | IMF |
|
| SSC03 | 24 cM | 5.15 | 0.000289 | IMF |
|
| SSC03 | 24 cM | 4.64 | 0.000725 | IMF |
|
| SSC05 | 124 cM | 4.95 | 0.000414 | - |
|
| SSC06 | 70 cM | 5.00 | 0.000379 | Vaccenic FA |
|
| SSC06 | 92 cM | 5.13 | 0.000300 | IMF |
|
| SSC07 | 72 cM | 5.35 | 0.000202 | Palmitoleic FA |
|
| SSC08 | 76 cM | 6.94 | 0.000012 | Myristic FA |
|
| SSC09 | 138 cM | 4.68 | 0.000675 | - |
|
| SSC14 | 44 cM | 4.78 | 0.000563 | Palmitoleic FA |
|
| SSC15 | 68 cM | 4.56 | 0.000838 | MUFA; PUFA |
|
| SSC18 | 40 cM | 4.98 | 0.000393 | Palmitic FA; SFA |
|
| SSC18 | 40 cM | 4.68 | 0.000675 | Palmitic FA; SFA |
IMF – intramuscular fat content; FA – Fatty Acid content (%); SFA – % saturated fatty acids; MUFA – % monounsaturated fatty acids; PUFA – % polyunsaturated fatty acids.
Genome-wide significant trans-eQTL for gluteus medius expression traits whose target genes are functionally related to lipid metabolism and fat deposition.
| eQTL location and significance | QTL positional concordance in the same population | |||||
|
| SSC | Position | F-value | Nominal | Positional Genes | Linked Trait |
|
| SSC01 | 10 cM | 4.69 | 0.000663 |
| - |
|
| SSC01 | 68 cM | 4.58 | 0.000808 |
| IMF |
|
| SSC02 | 92 cM | 5.03 | 0.000359 |
| Vaccenic FA |
|
| SSC02 | 122 cM | 4.53 | 0.000885 |
| - |
|
| SSC03 | 24 cM | 4.58 | 0.000808 |
| IMF |
|
| SSC03 | 28 cM | 5.44 | 0.000172 |
| IMF |
|
| SSC03 | 34 cM | 5.49 | 0.000157 |
| - |
|
| SSC03 | 58 cM | 4.96 | 0.000407 |
| - |
|
| SSC05 | 114 cM | 5.26 | 0.000237 |
| - |
|
| SSC06 | 66 cM | 5.53 | 0.000147 |
| Vaccenic FA |
|
| SSC06 | 70 cM | 5.11 | 0.000311 |
| Vaccenic FA |
|
| SSC06 | 94 cM | 4.77 | 0.000573 |
| IMF |
|
| SSC06 | 144 cM | 5.88 | 0.000079 |
| - |
|
| SSC07 | 132 cM | 4.64 | 0.000725 |
| IMF |
|
| SSC07 | 136 cM | 4.85 | 0.000496 |
| IMF |
|
| SSC07 | 136 cM | 4.53 | 0.000885 |
| IMF |
|
| SSC08 | 74 cM | 4.75 | 0.000594 |
| Myristic FA |
|
| SSC11 | 34 cM | 5.22 | 0.000255 |
| Muscle Cholesterol |
|
| SSC18 | 38 cM | 8.18 | 0.000001 |
| Palmitic FA; SFA |
Positional genes fitting in the confidence interval of the eQTL are indicated.
IMF – intramuscular fat content; FA – Fatty Acid content (%); SFA – % saturated fatty acids.
DAVID analysis of pathways significantly enriched in the list of cis- and trans-regulated genes.
| KEGG id | KEGG pathway name | Genes | Genes (n) |
| Fold Enrichment |
| 05410 |
|
| 9 | 0.002 | 3.739 |
| 04920 |
|
| 8 | 0.003 | 4.216 |
| 04960 | Aldosterone-regulated sodium reabsorption |
| 5 | 0.027 | 4.306 |
| 05219 | Bladder cancer |
| 5 | 0.029 | 4.204 |
| 04144 | Endocytosis |
| 11 | 0.034 | 2.111 |
| 04910 |
|
| 9 | 0.036 | 2.354 |
| 03320 |
|
| 6 | 0.044 | 3.071 |
| 04510 | Focal adhesion |
| 11 | 0.056 | 1.933 |
| 04110 | Cell cycle |
| 8 | 0.061 | 2.260 |
| 05200 | Pathways in cancer |
| 15 | 0.076 | 1.615 |
| 04350 |
|
| 6 | 0.097 | 2.435 |
In bold, pathways related to lipid and muscle metabolism and fat deposition.
Correlation coefficients (r) between muscle mRNA expression of several cis- and trans- regulated genes and intramuscular fat content, fatty acid profile and cholesterol content of the gluteus medius muscle.
| High group | Low group | Whole dataset | ||||||
| Regulated gene | QTL trait | R |
| r |
| r |
| |
|
| Linoleic FA | −0.08 | 0.5729 |
|
| −0.18 | 0.0670 | |
|
| Palmitoleic FA |
|
| 0.01 | 0.9643 | 0.19 | 0.0526 | |
| Linoleic FA |
|
| −0.22 | 0.1250 | 0.08 | 0.4191 | ||
| Stearic FA |
|
| −0.09 | 0.5429 |
|
| ||
|
|
| IMF |
|
| 0.16 | 0.2565 |
|
|
|
| Muscle Cholesterol | 0.16 | 0.2377 |
|
| 0.13 | 0.1713 | |
|
| Myristic FA |
|
|
|
|
|
| |
| Palmitoleic FA |
|
| −0.04 | 0.7929 | −0.03 | 0.7984 | ||
|
| Palmitic FA | 0.04 | 0.7829 |
|
| −0.14 | 0.1602 | |
|
| Palmitic FA |
|
| −0.13 | 0.4082 | 0.14 | 0.1712 | |
| Linoleic FA | −0.22 | 0.1035 |
|
| −0.02 | 0.8783 | ||
|
| IMF | 0.15 | 0.2669 |
|
|
|
| |
|
| IMF | −0.02 | 0.8688 |
|
| 0.18 | 0.0623 | |
| Palmitic FA | 0.04 | 0.7942 |
|
|
|
| ||
|
| Palmitoleic FA |
|
| −0.25 | 0.0713 |
|
| |
| Myristic FA | 0.25 | 0.0708 |
|
| 0.09 | 0.3623 | ||
| Linoleic FA | −0.23 | 0.0832 |
|
| −0.06 | 0.5432 | ||
| Palmitic FA |
|
| −0.04 | 0.7828 |
|
| ||
|
| Palmitoleic FA |
|
| −0.03 | 0.8497 | 0.15 | 0.1237 | |
| Linoleic FA |
|
|
|
| 0.07 | 0.4947 | ||
|
| Palmitic FA |
|
|
|
|
|
| |
|
| Muscle Cholesterol |
|
|
|
| −0.17 | 0.0890 | |
|
|
| Palmitoleic FA |
|
| 0.18 | 0.2045 | 0.05 | 0.6454 |
| Linoleic FA |
|
| 0.12 | 0.4153 | 0.07 | 0.4594 | ||
| Stearic FA |
|
| 0.01 | 0.9986 | 0.15 | 0.1449 | ||
| Muscle Cholesterol |
|
| 0.05 | 0.7523 | −0.12 | 0.2088 | ||
|
| Palmitoleic FA |
|
| 0.08 | 0.5585 | 0.08 | 0.4374 | |
| Myristic FA | 0.01 | 0.9834 |
|
| 0.16 | 0.1023 | ||
| Linoleic FA | 0.24 | 0.0859 |
|
| −0.15 | 0.1392 | ||
|
| Linoleic FA |
|
|
|
| 0.04 | 0.6706 | |
| Stearic FA |
|
| 0.05 | 0.7690 | 0.18 | 0.0755 | ||
|
| Palmitoleic FA |
|
| 0.21 | 0.1494 |
|
| |
| Linoleic FA |
|
| −0.17 | 0.2205 | 0.11 | 0.2434 | ||
IMF – intramuscular fat content; FA – Fatty Acid content (%).
Significant correlation coefficients are indicated in bold.